EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RANKL is downregulated in bone cells by physical activity (treadmill and vibration stimulation training) in rat with glucocorticoid-induced osteoporosis



RANKL is downregulated in bone cells by physical activity (treadmill and vibration stimulation training) in rat with glucocorticoid-induced osteoporosis



Histology and Histopathology 28(9): 1185-1196



The aim of this study was to investigate bone tissue and plasma levels of RANKL and OPG in rats with prednisolone-induced osteoporosis and to evaluate the outcomes of physical activity on the skeletal system by treadmill and vibration platform training. Osteoporosis is a disease characterised by low bone mass and structural deterioration of bone tissue leading to bone fragility. Vibration exercise is a new and effective measure to prevent muscular atrophy and osteoporosis. The animals were divided into 5 groups. 1: control rats; 2: rats with osteoporosis receiving prednisolone; 3: rats receiving prednisolone and treadmill training; 4: rats receiving prednisolone and vibration stimulation training; 5: rats receiving prednisolone, treadmill and vibration stimulation training. For bone evaluations we used whole-body scans, histology and histomorphometric analysis. RANKL and OPG expression was evaluated by immunohistochemistry and biochemical analysis. After treatment, our data demonstrated that RANKL expression was significantly increased in groups 2 and 3 and decreased in groups 4 and 5. Conversely, OPG expression was significantly decreased in groups 2 and 3 and increased in groups 4 and 5. In conclusion, our findings suggest that mechanical stimulation inhibits the activity of RANKL. This finding provides new insights into the occurrence and progression of osteoporosis.

(PDF emailed within 1 workday: $29.90)

Accession: 055333184

Download citation: RISBibTeXText

PMID: 23553492



Related references

The association of serum RANKL and OPG levels with other biochemical markers of bone turnover in glucocorticoid induced osteoporosis patients treated with hPTH. Journal of Bone & Mineral Research 17(Suppl 1): S209, September, 2002

Tetramethylpyrazine Protects Against Glucocorticoid-Induced Apoptosis by Promoting Autophagy in Mesenchymal Stem Cells and Improves Bone Mass in Glucocorticoid-Induced Osteoporosis Rats. Stem Cells and Development 26(6): 419-430, 2016

Glucocorticoid and Bone. Beneficial effect of teriparatide on fracture risk as well as bone mineral density in patients with glucocorticoid-induced osteoporosis. Clinical Calcium 24(9): 1379-1385, 2015

Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity. Bone 93: 43-54, 2016

The effects of physical activity on apoptosis and lubricin expression in articular cartilage in rats with glucocorticoid-induced osteoporosis. Journal of Bone and Mineral Metabolism 31(3): 274-284, 2014

Amyloid Deposits and Idiopathic Normal-Pressure Hydrocephalus: An 18F-Florbetaben Study. European Neurology 79(3-4): 192-199, 2018

A Novel Application of the Integra Camino Bolt for the Drainage of Chronic Subdural Hematoma: A Technical Note. Asian Journal of Neurosurgery 13(2): 380-382, 2018

Glucocorticoid induced stimulation of sodium potassium atpase activity in tubular epithelial cells is mediated by glucocorticoid receptors gr. Kidney International 31(1): 165, 1987

Pre-receptorial regulation of steroid hormones in bone cells: insights on glucocorticoid-induced osteoporosis. Journal of Steroid Biochemistry and Molecular Biology 108(3-5): 292-299, 2007

Glucocorticoid and Bone. The changes of Japanese and foreign guidelines for the management of glucocorticoid-induced osteoporosis. Clinical Calcium 24(9): 1301-1308, 2015

Glucocorticoid and Bone. Efficacy and safety of bisphosphonate in treatment of glucocorticoid induced osteoporosis. Clinical Calcium 24(9): 1371-1378, 2015

Glucocorticoid and Bone. Collagen cross-link abnormalities in glucocorticoid induced osteoporosis. Clinical Calcium 24(9): 1351-1359, 2015

Glucocorticoid and Bone. Updated Japanese guidelines for the management of glucocorticoid-induced osteoporosis. Clinical Calcium 24(9): 1309-1318, 2015

Glucocorticoid and Bone. Efficacy of active vitamin D on glucocorticoid-induced osteoporosis. Clinical Calcium 24(9): 1387-1392, 2015

Clinical review 83: Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. Journal of Clinical Endocrinology and Metabolism 81(10): 3441-3447, 1996